Need a report that reflects how COVID-19 has impacted this market and its growth?
The United States iodine market was estimated at around 8403.37 tons in 2021 and the market is estimated to register a CAGR of more than 3% during the forecast period (2022-2027).
The COVID-19 pandemic impacted the market in 2020. As a result of months of lockdowns, international travel bans, and retail business closures, sales, purchases, and usage fell across many end-user segments. However, the demand for iodine increased for end-user applications like medical, etc. during the pandemic.
- A major factor driving the market studied is the increasing demand from the medical sector, particularly after huge investments in the healthcare sector post the emergence of COVID-19.
- On the flip side, rising concerns about increasing health risks from excessive iodine intake are restraining the market growth.
- Iodine recycling is a major opportunity for the market studied in the future.
Scope of the Report
Iodine is a trace element that is naturally present in some foods, added to some types of salt, and available as a dietary supplement. The United States iodine market is segmented by source, form, and application. By source, the market is segmented into underground brines, caliche ore, recycling, and seaweeds. By form, the market is segmented into inorganic salts and complexes, organic compounds, elementals, and isotopes. By application, the market is segmented into animal feed, medical, biocides, optical polarizing films, fluorochemicals, nylon, and other applications. The report offers the market size and forecasts in volume (in tons) for all the above segments.
|Inorganic Salts and Complexes|
|Elementals and Isotopes|
|Optical Polarizing Films|
Key Market Trends
Increasing Demand from the Medical Sector
- Cancer is the second leading cause of mortality in the United States after heart disease. In 2022, the United States is anticipated to have 1.9 million new cancer cases and 609,360 cancer deaths, for a total of 1,670 deaths each day.
- Since the early 1940s, radioactive iodine (I-131) has been utilized to treat overactive thyroid diseases (hyperthyroidism). It is a highly successful therapeutic approach. It is becoming more commonly utilized as a first-line therapy than surgery.
- Radioactive iodine is absorbed by the thyroid and kills thyroid gland cells. This reduces the quantity of thyroxine produced by the thyroid gland and may also lower the gland's size.
- According to Statista, the revenue from the United States diagnostic imaging devices was USD 11,131 million in 2021, and it is expected to reach USD 13,504 million by 2026.
- Owing to the growing geriatric population, the demand for iodine for cancer treatment and medical imaging applications has been increasing steadily over the past few years.
To understand key trends, Download Sample Report
Underground Brine is the Most Used Source to Produce Iodine
- Iodine is primarily retrieved from underground brines. They are water with many dissolved salts and ions associated with natural gas and oil deposits.
- The underground brine is pumped up from the stratum to produce biogenic natural gas (NG) and iodine.
- In addition to this, underground brines are used in iodine production because they could be a potential source of rubidium, cesium, boron, or strontium.
- Iodine is produced from sodium iodide solutions found in underground brines associated with petroleum and natural gas fields. Iodine is also made from subterranean brines. Furthermore, the United States produces iodine from sodium iodide solutions.
- Underground brines can be classified as chloride, sulfate, and hydrocarbonate. Among all three, only chloride brines, including sodium, calcium, and magnesium, are widely found.
The US iodine market is highly consolidated. Some of the key players (not in any particular order) in the market studied include Iochem Corporation, Woodward Iodine Corporation (WIC) (Ise Chemicals Corporation), Iofina, and KIVA Holding Inc.
- In February 2022, Iofina was in negotiations with brine partners to create a new iodine plant, IO9. These negotiations are progressing, with the expectation to commence construction before 2022 ends. The company believes the outlook for iodine demand will remain strong in 2022.
Table of Contents
1.1 Study Assumptions
1.2 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1.1 Increasing Demand from the Medical Sector
4.1.2 Other Drivers
4.2.1 Health Risks from Excessive Iodine Intake
4.3 Industry Value Chain Analysis
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
5. MARKET SEGMENTATION
5.1.1 Underground Brines
5.1.2 Caliche Ore
5.2.1 Inorganic Salts and Complexes
5.2.2 Organic Compounds
5.2.3 Elementals and Isotopes
5.3.1 Animal Feed
5.3.4 Optical Polarizing Films
5.3.7 Other Applications
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share (%)**/Ranking Analysis
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 ACF Minera SA
6.4.2 American Elements
6.4.3 Deep Water Chemicals
6.4.4 Iochem Corporation
6.4.6 KIVA Holding Inc.
6.4.7 Samrat Pharmachem Limited
6.4.8 SQM SA
6.4.9 Woodward Iodine Corporation (WIC) (ISE Chemicals Corporation)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Iodine Recycling
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The United States Iodine Market market is studied from 2022 - 2027.
What is the growth rate of United States Iodine Market?
The United States Iodine Market is growing at a CAGR of >3% over the next 5 years.
Who are the key players in United States Iodine Market?
Iochem Corporation, WOODWARD Iodine CORPORATION , Iofina, KIVA Holding Inc are the major companies operating in United States Iodine Market.